Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Infusional Chemotherapy|January 1, 1995
Formal clinical evaluation of the CADD-Micro system for circadian delivery of FUDR in patients with metastatic renal cell cancerG A Bjarnason, N Doyle, M Sone, et al.
The Journal of Infusional Chemotherapy|October 1, 1996
Administrative and technical support of ambulatory infusional cancer chemotherapy (ICC)C Moore, D Strong
The Journal of Infusional Chemotherapy|July 1, 1996
The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD)E Aranda, A Cervantes, A Carrato, et al.
The Journal of Infusional Chemotherapy|July 1, 1996
High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancerT M Loeffler, T U Hausamen
The Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P Armand
The Journal of Infusional Chemotherapy|January 1, 1995
5-fluorouracil by protracted subcutaneous infusion. A pilot studyA Zaniboni, F Meriggi, A Alghisi, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188J Lokich, M Auerbach, L Essig, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomasM M Zalupski, L H Baker
The Journal of Infusional Chemotherapy|January 1, 1995
Surgical therapy for gastric cancerJ D Roder, H J Stein, K Böttcher, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Ambulatory chronotherapy with 5-fluorouracil, folinic acid, and carboplatin for advanced non-small cell lung cancer. A phase II feasibility trialC Focan, B Denis, F Kreutz, et al.
Pageof 7